PANACEA BIOTEC LTD. - 531349 - Standalone And Consolidated Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2022
We would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. May 18, 2022, inter-alia, considered and approved the following:- a. Standalone and Consolidated Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2022. The same were also reviewed by the Audit Committee in its meeting held earlier on May 18, 2022. A copy of the same along with the Auditors' Report is enclosed herewith as Annexure - A. b. Seeking shareholders' approval through Postal Ballot for : Appointment of Mr. Narotam Kumar Juneja (DIN: 01204817) as a Non-Executive Non-Independent Director; Adoption of new set of Articles of Association of Company; and Granting of loans, guarantees etc. and investment by way of acquisition of securities of any other bodies corporate & mutual funds etc. The meeting of the Board of Directors commenced at 12:30 P.M. and concluded at 2:40 P.M.18-05-2022